DMDD alleviates diabetic nephropathy by mitigating kidney damage and inflammation via the inhibition of the TLR4/MyD88/NF-κB signaling pathway (Lu et al., 2019). This evidence concerns the gene NFKB1 and diabetic kidney disease.